[Treatment of renal carcinoma].
The standard therapy for renal carcinoma is radical surgery. When dealing with single, under 4 cm tumors and in the case of renal tumors in single-kidney patients, the choice therapy is nephrectomy or partial nephrectomy. Response rates in metastatic renal carcinoma using the various immune therapy approaches available range from 15 to 35%, responses being short-lasting.
Arocena García-Tapia
J
J
Departamento de Urología, Clínica Universitaria de Navarra, Pamplona.
López Ferrandis
J
J
Sánchez Zalabardo
D
D
Regojo Balboa
J M
JM
Fernández Montero
J M
JM
Rosell Costa
D
D
Robles García
J E
JE
Zudaire Bergera
J J
JJ
Berián Polo
J M
JM
D003131:Combined Modality Therapy; D006801:Humans; D007680:Kidney Neoplasms / Q000628:therapy*